HealthDay News — Central adiposity measures are strongly associated with psoriasis risk, with a stronger association in women, according to a research letter published online May 27 in the Journal of ...

A new study has shed light on a surprising link between the way our bodies store fat – and the month we were born. While it’s ...

Low-dose colchicine therapy may not alter pericoronary adipose tissue attenuation but can help in improving plaque stability ...

Learn the crucial difference between weight loss and fat loss, why your scale lies, and how to achieve lasting health ...

Back pain affects more than 80 million people in Europe and is the most common cause of disability. If the pain persists for ...

Researchers at the Helmholtz Munich and the Ludwig-Maximilians-University (LMU) Munich have investigated a possible ...

NEW YORK – Arrowhead Pharmaceuticals on Monday said it has treated the first patients with ARO-ALK7, an RNAi therapeutic that the company is developing for obesity, within a first-in-human Phase I/IIa ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) has initiated the human trial of ARO-ALK7, a novel RNA interference (RNAi) ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has dosed the first subjects in a Phase 1/2a clinical trial of ARO-ALK7, the company’s investigational RNA interference (RNAi) ...

However, telangiectasias are also a classic feature of certain autoimmune diseases that affect the skin and other connective tissues (also called connective tissue diseases): There are many different ...